Synthesis of European Pharmacopoeial Impurities A, B, C, and D of Cabergoline† Cite This: RSC Adv., 2013, 3, 23146 Jernej Wagger,*A Aljaˇzpoˇzesb and Franc Poˇzganbc
RSC Advances View Article Online PAPER View Journal | View Issue Synthesis of European pharmacopoeial impurities A, B, C, and D of cabergoline† Cite this: RSC Adv., 2013, 3, 23146 Jernej Wagger,*a AljaˇzPoˇzesb and Franc Poˇzganbc For the use of analytics, European pharmacopoeial impurities A, B, C, and D of cabergoline were synthesized. Ergocryptine was chosen as a starting material and synthesis was accomplished via two approaches, different in length and stereochemical outcome. A longer, indirect approach was realized Received 4th July 2013 through otherwise problematic oxidations of the 9,10-dihidrolysergol derivative, to the corresponding Accepted 24th September 2013 aldehyde and carboxylic acid. This was achieved by the use of activated DMSO and a Pinnick oxidation DOI: 10.1039/c3ra43417f sequence. All four synthesized impurities are used as analytical standards in cabergoline manufacturing www.rsc.org/advances processes. Introduction acid (cabergolinic acid) A (Fig. 1). Primarily acting as a dopa- Creative Commons Attribution 3.0 Unported Licence. minergic D2 receptor agonist, cabergoline is most widely used Cabergoline (1) is a natural product-based drug, representing a for treatment of hyperprolactinaemic disorders and both early complex, branched amide of 6-N-allylated 9,10-dihydrolysergic and advanced Parkinson's disease.1 The structure of cabergo- line also encodes for different biogenic amines than dopamine, therefore displaying modest pharmacodynamic properties towards adrenergic and serotonergic receptors.1 One of the fundamental roles of the pharmaceutical industry is to develop new drugs that are safe, effective and of high This article is licensed under a quality when they reach the patients. With respect to this, delivering an impurity prole of an active pharmaceutical ingredient (API) is a must for fullling the aforementioned criteria.2 For the purpose of qualifying and/or quantifying the Open Access Article.
[Show full text]